Loading…
Reported covered position: Staff for Rep. Berkley
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: 340B HEALTH · Firm: 340B HEALTH
The 340B Drug Pricing Program, FY18 LHHS Appropriations, FY19 LHHS Appropriations, final 2018 Outpatient Prospective Payment System Rule, proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties, S.2312, S.2453, H.R.4710, H.R.4392
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2018 · first_quarter · Q1
The 340B Drug Pricing Program, FY18 LHHS Appropriations, FY19 LHHS Appropriations, final 2018 Outpatient Prospective Payment System Rule, proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties, S.2312, S.2453, H.R.4710, H.R.4392
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2017 · fourth_quarter · Q4
Source: Senate LDA
The 340B Drug Pricing Program, FY18 LHHS Appropriations, FY19 LHHS Appropriations, final 2018 Outpatient Prospective Payment System Rule, proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties, S.2312, S.2453, H.R.4710, H.R.4392
Helping Ensure Low-income Patients have Access to Care and Treatment
Client: 340B HEALTH · Firm: 340B HEALTH
The 340B Drug Pricing Program, FY18 LHHS Appropriations, FY19 LHHS Appropriations, final 2018 Outpatient Prospective Payment System Rule, proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties, S.2312, S.2453, H.R.4710, H.R.4392
The 340B Drug Pricing Program, FY18 LHHS Appropriations, FY19 LHHS Appropriations, final 2018 Outpatient Prospective Payment System Rule, proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties, S.2312, S.2453, H.R.4710, H.R.4392
Medicare Patient Access to Cancer Treatment Act of 2013
Client: 340B HEALTH · Firm: 340B HEALTH
FY14 Labor-HHS Appropriations Bill, H.R. 2869, Orphan Drug Rule, ACA implementation, 340B Drug Discount Program Congressional Oversight
Medicare Patient Access to Cancer Treatment Act of 2013
Client: 340B HEALTH · Firm: 340B HEALTH
FY14 Labor-HHS Appropriations Bill, Medicare Part B Drug Reimbursement, H.R. 2869, Orphan Drug Rule, ACA implementation, SGR reform pay-fors, 340B Drug Discount Program Congressional Oversight
Medicare Patient Access to Cancer Treatment Act of 2013
Client: 340B HEALTH · Firm: 340B HEALTH
- The 340B Drug Discount program - Medicare Part B Drug Reimbursement, H.R. 2869 - Orphan Drug Rule, ACA implementation - SGR reform pay-fors
Discussing the importance of the 340B drug discount pogram and improving program oversight. Advocating for the enactment of H.R. 2674.
Advocating for the passage of H.R. 2674. Extending 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Advocating for passage of H.R. 2674. Extending the 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Advocating for passage of H.R. 2674. Extending the 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Advocating for passage of H.R. 2674. Extending the 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Advocating for the passage of H.R. 2674. Extending 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
To amend the Small Business Act to provide for an increase in the amount of awards under the first and second phases of the Small Business Innovation Research program.
Client: 340B HEALTH · Firm: 340B HEALTH
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
To amend the Small Business Act to provide for an increase in the amount of awards under the first and second phases of the Small Business Innovation Research program.
Client: 340B HEALTH · Firm: 340B HEALTH
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
To amend the Small Business Act to provide for an increase in the amount of awards under the first and second phases of the Small Business Innovation Research program.
Client: 340B HEALTH · Firm: 340B HEALTH
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
The 340B Drug Pricing Program, FY18 LHHS Appropriations, final 2018 Outpatient Prospective Payment System Rule, final rule and new proposed rule concerning 340B ceiling price calculations and manufacturer civil monetary penalties
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2017 · third_quarter · Q3
The 340B Drug Pricing Program, FY18 LHHS Appropriations, Proposed 2018 Outpatient Prospective Payment System Rule, Interim Final Rule Delaying Effective Dates of 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2017 · second_quarter · Q2
The 340B Drug Pricing Program, FY18 LHHS Appropriations, Interim Final Rule Delaying Effective Dates of 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2017 · first_quarter · Q1
The 340B Drug Pricing Program, FY18 LHHS Appropriations, Interim Final Rule Delaying Effective Dates of 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2016 · fourth_quarter · Q4
The 340B Drug Pricing program, Health Resources and Services Administration 340B Drug Pricing Program Omnibus Guidance,FY17 Labor Health and Human Services Appropriations,Delaware Medicaid State Plan Amendment, CMS Medicaid and CHIP Managed Care Final Rule, CMS Covered Outpatient Drug Final Regulation, Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2016 · third_quarter · Q3
The 340B Drug Pricing program, Health Resources and Services Administration 340B Drug Pricing Program Omnibus Guidance,FY17 Labor Health and Human Services Appropriations,Delaware Medicaid State Plan Amendment, CMS Medicaid and CHIP Managed Care Final Rule, CMS Covered Outpatient Drug Final Regulation, Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates,Part B Drug Payment Model Proposed Rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2016 · second_quarter · Q2
The 340B Drug Pricing program, Health Resources and Services Administration 340B Drug Pricing Program Omnibus Guidance, FY17 Labor Health and Human Services Appropriations, Delaware Medicaid State Plan Amendment, CMS Medicaid and CHIP Managed Care Final Rule, CMS Covered Outpatient Drug Final Regulation,340B Ceiling Price and Manufacturer Civil Monetary Penalties Regulation, Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates,Part B Drug Payment Model Proposed Rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2016 · first_quarter · Q1
The 340B Drug Pricing program, Health Resources and Services Administration 340B Drug Pricing Program Omnibus Guidance, FY17 Labor Health and Human Services Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2015 · fourth_quarter · Q4
The 340B Drug Pricing program and the Health Resources and Services Administration 340B Drug Pricing Program Omnibus Guidance.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2015 · third_quarter · Q3
The 340B Drug Discount Program, HRSA's Mega-guidance
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2015 · second_quarter · Q2
The 340B Drug Discount Program, HRSA's Mega-guidance, 21st Century Cures legislation.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2015 · second_quarter · RA
The 340B Drug Discount Program.
The 340B Drug Discount Program.
2015 · first_quarter · Q1
The 340B Drug Discount Program, HRSA's Mega-guidance and audits of covered entities, Fiscal Year 16 Labor-HHS Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2014 · fourth_quarter · Q4
FY15 Labor-HHS Appropriations, 340B Drug Discount Program, Definition of covered outpatient drug, Medicaid Managed Care, 340B patient definition.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2014 · third_quarter · Q3
FY15 Labor-HHS Appropriations, Orphan Drug Rule, 340B Drug Discount Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2014 · second_quarter · Q2
FY14 Labor-HHS Appropriations Bill, H.R. 2869, Orphan Drug Rule, ACA implementation, 340B Drug Discount Program Congressional Oversight
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2014 · first_quarter · Q1
FY14 and FY 15 Labor-HHS Appropriations Bill, 340B Drug Discount Program Congressional Oversight, HRSA's expected 2014 Mega-Rule on 340B, cancer drug reimbursement, hospital reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2013 · fourth_quarter · Q4
FY14 Labor-HHS Appropriations Bill, Medicare Part B Drug Reimbursement, H.R. 2869, Orphan Drug Rule, ACA implementation, SGR reform pay-fors, 340B Drug Discount Program Congressional Oversight
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2013 · third_quarter · Q3
- The 340B Drug Discount program - Medicare Part B Drug Reimbursement, H.R. 2869 - Orphan Drug Rule, ACA implementation - SGR reform pay-fors
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2013 · second_quarter · Q2
Discussing the importance of the 340B drug discount program and improving program oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2013 · first_quarter · Q1
Discussing the importance of the 340B drug discount program and improving program oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2012 · fourth_quarter · 4A
Discussing the importance of the 340B drug discount program and improving porgram oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2012 · fourth_quarter · Q4
Discussing the importance of the 340B drug discount program and improving program oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2012 · third_quarter · Q3
Discussing the importance of the 340B drug discount program and improving program oversight. Advocating for extension of program to the inpatient setting and repeal of the orphan drug ban.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, White House Office
2012 · second_quarter · Q2
Discussing the importance of the 340B drug discount pogram and improving program oversight. Advocating for the enactment of H.R. 2674.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2012 · first_quarter · Q1
Improving 340B program integrity. Advocating to extend the 340B drug discount program to the inpatient setting in eligible hospitals. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing orphan drug discount prohibition for certain covered entities.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2011 · fourth_quarter · RA
Advocating for passage of H.R. 2674. Extending the 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Advocating for passage of H.R. 2674. Extending the 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
2011 · fourth_quarter · Q4
Advocating for the passage of H.R. 2674. Extending 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2011 · third_quarter · Q3
Advocating for the passage of H.R. 2674. Extending 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2011 · second_quarter · RA
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals; Improving program integrity. Preserving 340B patient definition and Medicaid reimbursement to 340B covered entities. Reversing 340B orphan drug prohibition for certain covered entities.
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals; Improving program integrity. Preserving 340B patient definition and Medicaid reimbursement to 340B covered entities. Reversing 340B orphan drug prohibition for certain covered entities.
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals; Improving program integrity. Preserving 340B patient definition and Medicaid reimbursement to 340B covered entities. Reversing 340B orphan drug prohibition for certain covered entities.
2011 · second_quarter · Q2
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals; Improving program integrity. Preserving 340B patient definition and Medicaid reimbursement to 340B covered entities. Reversing 340B orphan drug prohibition for certain covered entities.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2011 · first_quarter · 1A
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2011 · first_quarter · Q1
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2011 · first_quarter · RA
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
2010 · fourth_quarter · Q4
Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2010 · third_quarter · RA
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
2010 · third_quarter · Q3
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Advocating for passage of H.R. 2674. Extending the 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities.